Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 80943610286

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80943610286 and manufactured by SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. The registration is held by MINDRAY DO BRASIL COMÉRCIO E DISTRIBUIÇÃO DE EQUIPAMENTOS MÉDICOS LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80943610286
Registration Details
ANVISA Registration Number: 80943610286
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família Coluna analítica para hemoglobina A1c
Risk Class II

Registration Details

80943610286

25351113440202533

09058456000187

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Sep 01, 2025

VIGENTE

09/18/2025 19:00:01